REDWOOD CITY, Calif., Jan. 21, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...
It has been about a month since the last earnings report for Nevro (NVRO). Shares have lost about 16% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...
The company announced receiving CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. Nevro raised its 2024 adjusted EBITDA loss guidance to $18 million-$16 million from its ...
REDWOOD CITY, Calif., April 2, 2020 /PRNewswire/ -- Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results